<dd id='83f2g'><tbody id='83f2g'><td id='83f2g'><optgroup id='83f2g'><strong id='83f2g'></strong></optgroup><address id='83f2g'><ul id='83f2g'></ul></address><big id='83f2g'></big></td><table id='83f2g'></table></tbody><pre id='83f2g'></pre></dd><span id='83f2g'><b id='83f2g'></b></span>
<dfn id='83f2g'><optgroup id='83f2g'></optgroup></dfn><tfoot id='83f2g'><bdo id='83f2g'><div id='83f2g'></div><i id='83f2g'><dt id='83f2g'></dt></i></bdo></tfoot>
<ul id='83f2g'></ul>
<fieldset id='83f2g'></fieldset>
凌科藥(yao)業(杭州)有限公司宣布其自主(zhu)研發的1類(lei)創(chuang)新藥(yao)LNK01004的臨床(chuang)Ⅰ期研究在中(zhong)國(guo)完成首例受試者給(gei)藥(yao)。LNK01004是(shi)一款新型激酶抑制(zhi)劑，可(ke)用于治療銀屑病(bing)。(醫(yi)藥(yao)健(jian)聞)
<dd id='skuhn'><tbody id='k51bc'><td id='HXOSG'><optgroup id='4SRAg'><strong id='LWw6B'></strong></optgroup><address id='rCIim'><ul id='AVxle'></ul></address><big id='Fm1R9'></big></td><table id='wrveE'></table></tbody><pre id='NITBP'></pre></dd><span id='ee453'><b id='FYyP6'></b></span>
<dfn id='XYGeI'><optgroup id='fib4V'></optgroup></dfn><tfoot id='7wEl0'><bdo id='VMhRb'><div id='IKU0a'></div><i id='X6Yam'><dt id='ZYWND'></dt></i></bdo></tfoot>
<ul id='SBLrC'></ul>
<fieldset id='f1gQs'></fieldset>
